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Background. Retro-orbital radiotherapy in patients with Graves’ disease is a technique widely used as initial local therapy and for
patients refractory to other treatments. Advances in radiotherapy have improved dosimetric parameters minimizing damage to
surrounding structures.
Objectives. Compare with the standard technique of irradiation, new technologies used in radiotherapy, such as IMRT.
Methods. We present a case of a 50-years old woman with bilateral symptomatic Graves’ disease. The patient was referred
after ineffective treatment (corticosteroids). An individual 3DCRT (using two laterals ﬁelds) and IMRT (6 ﬁelds, adding oblique
posterior and coronal) was created. Radiation dose was 20Gy in 10 fractions. Conformity index (CI), homogeneity index (HI) and
other dosimetric parameters of organs at risk (globes, lenses, pituitary gland and optic chiasm) were compared.
Results. Similarly CI was generated by IMRT and 3DRTC (1.3 vs 1.5). IH was described <2.5 for both plans (1.05 vs 1.06 respectively).
IMRT gave rise to better dose sparing to surrounding structures as compared with 3DRTC (mean doses, on Gy): lenses (1.77 vs
3.14 on right, and 2.13 vs 3.57 on left), globes (8.31 vs 9.89 on right, and 7.85 vs 9.87 on left), pituitary gland (0.69 vs 1.41) and optic
chiasm (0.82 vs 2.38).
Conclusions. Retro-orbital irradiation is an effective and well tolerated local therapy for Graves’ disease. As compared with 3DCRT,
IMRT have similar target coverage and show better dose sparing to organ as risk. Its routine use must be supported by larger
series and longer follow-up.
http://dx.doi.org/10.1016/j.rpor.2013.03.375
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Introduction. Patients receiving craniospinal irradiation are at a signiﬁcant risk to develop late sequelae due to the close proximity
of radiosensitive organs to the target volume. The feasibility of using VMAT to reduce the organs-at-risk dose was evaluated.
Purpose. To describe our procedure of VMAT pediatric craniospinal irradiation (CSI).
Method. The patient is a 4 year’s old child diagnosed in 2009 of Leukaemia with brain’s inﬁltration. Fourth relapse in SNC occurred
in 2012 in treatment with chemotherapy. The patient was immobilized by eXaFrame (Anatomical-Geometry) and treatment
design was performed in Pinnacle v9.2. (Philips). An auxiliary contour (CPE) is created as the external contour minus 12mm.
The upper target is created as brain minus CPE plus part of the spinal channel, up to C3. After this contour there is a space of
2 slices without any contour. Later on, four structures of transition (2 cm of length). The upper target is calculated by means of
two double arches VMAT (160–60◦ and 300–200◦) and the following objectives: Dmax =16.5Gy, (weight = 1), uniform dose=15.50
(weight = 50)and Dmin = 15Gy (weight = 1); Dmin of T1, T2, T3 and T4 are set to 80%, 60% 40% and 20% of 15Gy. Once the upper
treatment is optimized, the spinal is planned. Two VMAT arcs of 178–115◦ and 235–182◦ are selected. The new goals are: uniform
dose 15.5Gy (weight = 50) for lower target, Dmax for lungs of 10Gy (weight = 1) and for all structures of transition uniform dose of
15Gy.
Results. The acute toxicity has been minimal, with nauseas during the ﬁrst three days of treatment, and hematologic toxicity I.
The body dose did not surpass 16.3Gy with an average dose of 4.8Gy. Maximum dose for the lungs was 11.9Gy, with an average
of 2.8Gy.
Conclusion. Our technology that overlaps VMAT’s arches is very efﬁcient and competitive procedure.
http://dx.doi.org/10.1016/j.rpor.2013.03.376
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Introduction. Treatment delays in completing radiotherapy (RT) in head and neck cancer (H&NC) is a major problem revealed by
the growing published evidence. Overall treatment time (OTT) may be a critical predictor regarding tumor control and/or survival.
Materials and methods. An extensive bibliographic search was performed looking for papers analyzing possible relationships
between OTT prolongation and loco-regional control rates (LRC) or survival (SV) in H&NC. We searched in evidence-based
databases, including MEDLINE original articles, using a broad strategy of free terms included in the Title/Abstract, such as
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“tumoral repopulation”, “radiotherapy delays”, “treatment interruptions”, “overall treatment time”, etc. Additionally, we traced
the bibliographic references indicated in the articles previously selected. Special attentionwas paid in the quality of data reported,
carefully divided into univariate or multivariate analysis.
Results. Fifty-ﬁve papers were considered to ﬁt the purposes of the present study: 49 original data from retrospective series and 3
were pooled-data analysis of previously published series, with a median of 426 patients per article (range 42–4668). The other 3
papers included one editorial, one commentary and a literature review. Larynx was the most frequently reported site (22 articles,
40%), followed by mixed locations (19 articles, 35%) and oropharynx (5 articles, 9%). The majority of the original and pooled-data
studies (46/52–88.4%) showed some evidence of a negative relationship between OTT prolongation and LRC or SV. From 50 articles
that analyzed LRC, 44 (88%) showed a signiﬁcant deleterious effect of OTT prolongation, 27 of them by multivariate analyses.
And from 16 articles reporting SV data, 14 (87.5%) showed the same effect, 10 of them by multivariate analyses.
Conclusions. Consistent evidence exists about a negative outcome in LRC and SV, when OTT is prolonged during a RT course
for H&NC. Over 88% of the studies reporting LRC and/or SV endpoints showed its detrimental effect, mostly by multivariate
analysis of restrospective data. Taking into account the overwhelming ethical difﬁculties to perform any randomized clinical
trial, prospective or retrospective observational studies are the unique evidence available to deal with this important issue.
http://dx.doi.org/10.1016/j.rpor.2013.03.377
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Introduction. Medulloblastoma is the most common malignant childhood brain tumor. Radiotherapy to the craniospinal axis (CSI)
with a boost to the posterior fossa has been standard practice. The standard for CSI has been photon therapy that included
opposed lateral cranial ﬁelds and either single or multiple posterior spinal ﬁelds in prone position, in order to conﬁrm the
junction shifts. This is an uncomfortable and difﬁcult position for children. The new irradiation techniques could help us to
improve the positioning and the reproducibility of treatment.
Methods. Standard of care treatment plans were developed in supine position in one patient for both 3D and Rapid Arc CSI. Patient
underwent computed tomography (multi-slice CT scan) simulation in the supine position. Differences in planswere evaluated for
various dosimetric parameters for the target volumen and normal tissues. Three dosimetric parameters were evaluated for the
CTV: the maximum dose (Dmax), the conformity index (CI: VRx/VEv) and the heterogeneity index (HI: D5%/D95%). We evaluated
V20, V15, V10 and V5 for six partially in-ﬁeld and out-of-ﬁeld organs.
Results. Four arcs/two isocentres/table 0◦ were employed in Rapid Arc plan and four ﬁelds/two isocentres/table in 0◦ and 90◦ in
3D plan. CI were 0.99 and 0.90 for Rapid Arc and 3D plans respectively, indicating that the dose distribution conformed well to
the CTV and it is better for Rapid Arc. Moreover, Dmax was greater for 3D plan (higher doses to a large percentage of volumen)
and the same for HI indicating a more heterogeneous distribution. When we compared the results in relation to normal tissues,
all values related to V20, V15 and V10 were higher for 3D plan than for Rapid Arc plan.
Conclusions. CSI with Rapid Arc technique in supine position is feasible, safety and reproductible, face-lifting the treatment
(comfortable positioning, no table movements) and reducing dose to normal tissues in children population who are at high risk
of developing late toxicities.
http://dx.doi.org/10.1016/j.rpor.2013.03.378
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Introduction. Total body irradiation (TBI) has an established role as preparative regimen for bone-marrow transplantation (BMT) in
the treatment of some hematological malignancies. This preparative regimen remains always associated with a relatively high
rate of toxicity.
Objective. Report the experience in TBI treatment the last 5 years in our Hospital.
Materials and methods. We report a retrospective analysis of the patients who underwent TBI for conditioning prior to BMT for
hematologic disease between January/2006 and December/2011. Were treated 12 patients (8 women and 4 men), the age of the
patients was between 9 and 54 years (median 29.5years). They had diagnoses of LLA in 58.4% and LMA in 41.6%. Eleven patients
had induction chemotherapy with PETHEMA and one with SHOP. Complete response before radiotherapy in 66.6% and partial
in 33.3%. Radiotherapy was administrated with cobalt-60 in 25% and linear accelerator in 75%. All of them received 12Gy twice
daily along 3 days. Pulmonary dose was ≤8Gy. Transplant allogeneic in 75% and autologus in 25%.
